Navigation Links
Valeant Pharmaceuticals Announces Private Exchange Offer
Date:3/29/2013

he Company (such date and time, as the same may be extended or earlier terminated, the "Expiration Time"). Eligible holders that validly tender their Existing Notes and do not withdraw their tenders at or prior to 5:00 p.m., New York City time, on April 9, 2013 (such date and time, the "Initial Expiration Time") will receive Exchange Notes on April 10, 2013.

Tenders in the Exchange Offer may be validly withdrawn at any time prior to the Initial Expiration Time, but will thereafter be irrevocable, except as required by applicable securities laws. 

The Company may extend or terminate the Exchange Offer, in its sole and absolute discretion, and otherwise amend or modify the Exchange Offer in any respect, subject to applicable securities laws.  The Exchange Offer is open to all eligible holders of Existing Notes. 

The Exchange Notes have not been and will not be registered under the Securities Act of 1933, as amended (the "Securities Act") or any state securities laws.  The Exchange Notes may not be offered or sold in the United States or to any U.S. persons except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act.  The Exchange Offer is being made, and the Exchange Notes are being offered, and issued only to holders of Existing Notes who are "qualified institutional buyers" (as defined in Rule 144A under the Securities Act) or institutional "accredited investors" within the meaning of Rule 501 (a)(1), (2), (3) or (7) of Regulation D under the Securities Act.

This announcement shall not constitute an offer to sell or the solicitation of an offer to buy securities, nor shall there be any offer or sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.

About
'/>"/>

SOURCE Valeant Pharmaceuticals International, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical
2. Valeant Pharmaceuticals Reports 2012 First Quarter Financial Results
3. Valeant Pharmaceuticals To Host Investor Day
4. Valeant Pharmaceuticals To Announce 2012 Second Quarter Results On August 2, 2012
5. Valeant Pharmaceuticals International, Inc. Agrees To Acquire Medicis Pharmaceutical Corporation For $44.00 Per Share In Cash
6. Valeant Pharmaceuticals To Present At UBS Annual Global Life Sciences Conference
7. Valeant Pharmaceuticals Announces Management Change
8. Valeant Pharmaceuticals To Syndicate Incremental Loans
9. Valeant Pharmaceuticals Appoints Howard Schiller To Board Of Directors
10. Valeant Pharmaceuticals Announces Launch of Concurrent Private Offerings of Senior Notes
11. Valeant Pharmaceuticals International, Inc. Announces Pricing Of Concurrent Private Offerings Of Senior Notes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HOUSTON , Oct. 22, 2014  Charlene Vernak, RPh, ... York , recently was awarded the George Roentsch ... Vernak received the award in Houston ... The scholarship is awarded annually to an independent pharmacist ... nature of George Roentsch , a well-known pharmacist ...
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... , Oct. 21, 2014  Early symptoms ... subtle or unnoticed, but new technology, coupled with ... and leading to earlier detection of eye diseases, ... 29 million Americans. If left untreated, these diseases ... blindness. Recently, optometric researchers have ...
Breaking Medicine Technology:PCCA Awards Charlene Vernak, RPh, the George Roentsch Scholarship 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 2Technology Advancements Enhance Early Detection of Eye Diseases Associated with Diabetes 3
... Delcath Systems, Inc. (Nasdaq: DCTH ), a developmental stage ... that it will open the NASDAQ stock market on Friday, ... Times Square in New York City will be broadcast ... NASDAQ webcam. The live ceremony, including President and Chief Executive Officer ...
... Inc. (Nasdaq: MYL ) today announced that it increased the ... pricing.  Mylan priced $550 million aggregate principal amount of ... and $700 million aggregate principal amount of 7.875% Senior ... to use approximately $1.0 billion of the net proceeds ...
Cached Medicine Technology:Delcath's Eamonn Hobbs to Ring NASDAQ Opening Bell 2Mylan Announces Upsizing and Pricing of Senior Notes 2Mylan Announces Upsizing and Pricing of Senior Notes 3
(Date:10/22/2014)... 2014 Isabel Healthcare will ... Professions (ASAHP) Conference on October 22-24 in Las Vegas, ... in a panel discussion on Technology in Health Professions ... provides a diagnostic decision support tool and clinical education ... of students and clinical learners. The Isabel tools help ...
(Date:10/22/2014)... The Louis W. Sullivan ... to distribute health information technology innovation to transform ... the development of six key guiding principles of ... healthcare. These are an expansion of the Institute ... that is respectful of and responsive to individual ...
(Date:10/22/2014)... Texas (PRWEB) October 22, 2014 ... of completing their continuing education at home or ... have access to 20 brand new, premium Seminar-on-Demand ... robust catalog of over 2,000 hours ... fully customize their educational experience. With such a ...
(Date:10/22/2014)... 22, 2014 Akeso Biomedical, Inc. ... the treatment of bacterial infections, microbial biofilms, and chronic ... its board of directors. , Dr. Sinskey ... at The Massachusetts Institute of Technology, or MIT. He ... 1968. Dr. Sinskey also holds positions as Co-Director of ...
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. 21, 2014 ... fertilization (IVF) -- the incubation of embryos in a laboratory ... the vagina, new research suggests. Scientists from the United ... might sharply cut costs for pricey IVF procedures among certain ... those who don,t live near big-city assisted reproduction centers, the ...
Breaking Medicine News(10 mins):Health News:Isabel Healthcare to Participate in The Association of Schools of Allied Health Professions (ASAHP) 2014 Conference 2Health News:The Sullivan Institute for Healthcare Innovation Announces Release of Guiding Principles for Patient Experience-Centered Care 2Health News:Top Provider of Continuing Education at Home Releases 20 New Online Courses 2Health News:Akeso Biomedical Appoints Dr. Anthony J. Sinskey to Board of Directors 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4
... , TONBRIDGE, England, Sept. ... innovation of the past 150 years, by leading figures in the ... the electric light bulb and penicillin in a star-studded competition organised ... The final four inventions went head-to-head in a live debate, with ...
... , , MIDDLETOWN, Conn., Sept. ... Blue Cross and Blue Shield Foundation grant to the national ... $37,500 to fund the "Family Link" program here in Connecticut. ... community-based network that connects parents of children with diabetes with ...
... , , ... (AFA) today applauded Senate Finance Committee Chairman Max Baucus (D-MT) ... including cognitive impairment screening for Medicare beneficiaries in Baucus, healthcare ... , , AFA had pressed for cognitive ...
... , , , MINNEAPOLIS, Sept. ... health by helping yogurt lovers regulate digestive health without compromising calorie ... Available in three delicious flavors -- Honey Vanilla, Strawberry Banana and ... Light is an easy way to help keep your digestive health ...
... , , , NEW YORK, Sept 17 ... today announced that it will host The Runyon 5K , ... on Sunday, November 15th 2009. Proceeds from the event, the first of ... scientists carrying out innovative research for all types of cancer. , ...
... Sept. 17, 2009 The Wellcome Trust and Merck ... MSD Wellcome Trust Hilleman Laboratories ( www.hillemanlaboratories.in ), the ... with a not-for-profit mission to focus on developing affordable ... The joint venture marks the first ...
Cached Medicine News:Health News:Contraceptive Pill Named the Greatest Pharmacy Invention of the Last 150 Years in Chemist+Druggist Competition 2Health News:Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Association's 'Family Link' Program In Connecticut 2Health News:Anthem Blue Cross and Blue Shield Foundation Grant Supporting American Diabetes Association's 'Family Link' Program In Connecticut 3Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Proposal 2Health News:Alzheimer's Foundation of America Applauds Inclusion of Cognitive Screening for Medicare Beneficiaries in Senate Finance Committee Health Reform Proposal 3Health News:Photos: New Yoplait(R) YoPlus(TM) Light... A Delicious Way to Regulate Digestive Health With Fewer Calories 2Health News:Photos: New Yoplait(R) YoPlus(TM) Light... A Delicious Way to Regulate Digestive Health With Fewer Calories 3Health News:Damon Runyon 5K Run/Walk at Yankee Stadium to Benefit Cancer Research 2Health News:Damon Runyon 5K Run/Walk at Yankee Stadium to Benefit Cancer Research 3Health News:Damon Runyon 5K Run/Walk at Yankee Stadium to Benefit Cancer Research 4Health News:Wellcome Trust and Merck launch joint venture to develop affordable vaccines 2Health News:Wellcome Trust and Merck launch joint venture to develop affordable vaccines 3Health News:Wellcome Trust and Merck launch joint venture to develop affordable vaccines 4
Anesthesia Associates Nerve Stimulator Model AA 1050...
... A range of easy to use instruments ... nerve locator, peripheral nerve stimulator, and muscle ... pole, plastic hub, and pencil point needles., ... inexpensive, practical and easy to use stimulator, ...
... nerve stimulator from B. Braun Medical. It ... stimulator functionality for over 10 years. , ... a unique, under-the-glove hand held remote current ... It allows the anesthesia provider operating solo ...
... the original MS-III design the ... enhanced keypad and ... MiniStim® MS-IV peripheral nerve stimulator ... monitoring in operating room, post ...
Medicine Products: